Business Description
VentriPoint Diagnostics Ltd
NAICS : 621511
SIC : 8633
ISIN : CA92281P2008
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | -3.43 | |||||
Debt-to-Equity | -0.59 | |||||
Debt-to-EBITDA | -0.3 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -133.86 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -12.6 | |||||
3-Year EPS without NRI Growth Rate | -14.5 | |||||
3-Year FCF Growth Rate | -17 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.89 | |||||
9-Day RSI | 38.4 | |||||
14-Day RSI | 37.57 | |||||
6-1 Month Momentum % | -31.35 | |||||
12-1 Month Momentum % | -43.8 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.28 | |||||
Quick Ratio | 0.28 | |||||
Cash Ratio | 0.06 | |||||
Days Sales Outstanding | 37.3 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -20.3 | |||||
Shareholder Yield % | -2.57 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -3643.07 | |||||
Net Margin % | -3719.71 | |||||
FCF Margin % | -2644.12 | |||||
ROA % | -361.83 | |||||
ROIC % | -1258.45 | |||||
ROC (Joel Greenblatt) % | -2145.58 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -3.34 | |||||
EV-to-EBITDA | -3.38 | |||||
EV-to-Revenue | 119.63 | |||||
EV-to-FCF | -4.68 | |||||
Earnings Yield (Greenblatt) % | -29.94 | |||||
FCF Yield % | -22.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VPTDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return %
Total Annual Return %
VentriPoint Diagnostics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.102 | ||
EPS (TTM) ($) | -0.028 | ||
Beta | 1.34 | ||
Volatility % | 81.99 | ||
14-Day RSI | 37.57 | ||
14-Day ATR ($) | 0.010415 | ||
20-Day SMA ($) | 0.090395 | ||
12-1 Month Momentum % | -43.8 | ||
52-Week Range ($) | 0.06136 - 0.2687 | ||
Shares Outstanding (Mil) | 157.81 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
VentriPoint Diagnostics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
VentriPoint Diagnostics Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
VentriPoint Diagnostics Ltd Frequently Asked Questions
What is VentriPoint Diagnostics Ltd(VPTDF)'s stock price today?
When is next earnings date of VentriPoint Diagnostics Ltd(VPTDF)?
Does VentriPoint Diagnostics Ltd(VPTDF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |